Non-small Cell Lung Cancer
Non-small cell lung cancer (NSCLC) is a type of lung cancer that includes several subtypes and is characterized by uncontrolled cell growth in lung tissues. It is the most common type of lung cancer.
We are investigating a new treatment for patients with advanced solid tumors. The goal is to see if it can improve outcomes compared to current therapies.
Health conditions and diseases that the clinical trial is designed to study and treat.
Non-small cell lung cancer (NSCLC) is a type of lung cancer that includes several subtypes and is characterized by uncontrolled cell growth in lung tissues. It is the most common type of lung cancer.
Oesophageal squamous cell carcinoma is a type of cancer that occurs in the squamous cells lining the esophagus, often leading to symptoms like difficulty swallowing and weight loss.
Gastric cancer, or stomach cancer, is a type of cancer that starts in the stomach lining and can cause symptoms such as indigestion, stomach pain, and nausea.
Squamous cell carcinoma of the head and neck is a type of cancer that arises in the squamous cells of the head and neck region, often presenting with symptoms like a sore throat and difficulty swallowing.
Head and neck squamous cell carcinoma is a cancer that originates in the squamous cells of the head and neck area, leading to symptoms such as a persistent sore throat and changes in voice.
Malignant melanoma is a serious form of skin cancer that develops from melanocytes, the cells that produce pigment in the skin, and can appear as a new or changing mole.
Triple negative breast cancer (TNBC) is a type of breast cancer that does not have any of the three common receptors known to fuel most breast cancer growth, making it more challenging to treat.
Ovarian cancer is a type of cancer that begins in the ovaries and can cause symptoms such as abdominal bloating, pelvic pain, and changes in bowel habits.
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.